Corvus Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Corvus Pharmaceuticals patents 14 in total
| Status | Patent |
|---|---|
Application | Utility: B-CELL ACTIVATING CD73 ANTIBODIES Filling date: 27 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: HUMANIZED ANTI-CD73 ANTIBODIES Filling date: 27 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY ACTIVATION Filling date: 27 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY ACTIVATION Filling date: 27 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: ANTI-CD73 ANTIBODIES Filling date: 27 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: METHODS OF TREATING CANCER Filling date: 27 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: METHODS FOR TREATING CD73HI TUMORS Filling date: 27 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: PHARMACEUTICAL FORMULATIONS Filling date: 27 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: ADENOSINE PATHWAY INHIBITORS FOR CANCER TREATMENT Filling date: 27 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: METHODS OF TREATING CANCER Filling date: 27 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: COMBINATION THERAPY FOR CANCER TREATMENT Filling date: 27 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR Filling date: 27 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE Filling date: 27 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: PHARMACEUTICAL FORMULATIONS Filling date: 27 Sep 2025 Issue date: 1 Aug 2019 |
Showing 1 to 14 of 14 patents.